Compare TECH & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECH | SNEX |
|---|---|---|
| Founded | 1976 | 1924 |
| Country | United States | United States |
| Employees | N/A | 5400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 8.9B |
| IPO Year | 1995 | 1996 |
| Metric | TECH | SNEX |
|---|---|---|
| Price | $71.08 | $134.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $71.82 | ★ $81.33 |
| AVG Volume (30 Days) | ★ 4.6M | 889.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.81 | ★ 3.74 |
| Revenue | $1,219,635,000.00 | ★ $132,378,200,000.00 |
| Revenue This Year | $2.49 | N/A |
| Revenue Next Year | $6.40 | $4.17 |
| P/E Ratio | $87.28 | ★ $36.73 |
| Revenue Growth | 5.23 | ★ 32.53 |
| 52 Week Low | $43.20 | $68.97 |
| 52 Week High | $72.16 | $141.99 |
| Indicator | TECH | SNEX |
|---|---|---|
| Relative Strength Index (RSI) | 78.36 | 63.20 |
| Support Level | $56.38 | $105.27 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.03 | 6.12 |
| MACD | 1.75 | 0.43 |
| Stochastic Oscillator | 99.43 | 69.10 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.